RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 1,027,722 shares at $6.91 ($7.7M) on 2026-06-09, disclosed to the SEC on 2026-06-11.
Open-market purchase of $7.7M ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.91 | 479,039 | $3.3M | 43.3% |
| 2 | $7.00 | 103 | $721 | 0.0% |
| 3 | $7.91 | 548,580 | $4.3M | 56.7% |
| Total | $7.44 avg | 1,027,722 | $7.7M | 100% |
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |